Back to contents

Highlights from CROI 2009

Published: 19 February 2009

This edition of HATIP is devoted to news headlines from last week’s Sixteenth Conference on Retroviruses and Opportunistic Infections, held in Montréal, Canada. We published comprehensive news coverage from this conference at aidsmap.com.

CROI is one of the major HIV-related scientific meetings of the year, and many of the most important presentations at this year’s conference were of research conducted in Africa and Asia that will be directly relevant to the care of people with HIV and prevention of HIV infection in those settings.

This bulletin divided into five sections, each highlighting the major studies presented in those areas at the conference. Of particular note are the following:

  • Opportunistic infection management and prophylaxis: a large randomised study demonstrated that prophylaxis with fluconazole reduced the risk of cryptococcal meningitis in people with advanced HIV disease, while another study showed that use of the steroid prednisone improved the outcomes of people with TB-related immune reconstitution inflammatory syndrome (IRIS).
  • Antiretroviral treatment reduced the risk of HIV transmission within HIV-discordant partnerships in two separate studies in Uganda, Rwanda and Zambia.
  • The first evidence of microbicide effectiveness, from the HPTN 035 study, showing that PRO2000 reduced the risk of HIV infection by around 30%. Results of another major study, due to finish by the end of 2009, are awaited in order to confirm this result.
  • Late treatment initiation in resource-limited settings continues to confer an increased risk of death for years afterwards, due to the prolonged period individuals spend with very low CD4 counts.
  • Antiretroviral treatment for mothers during the breastfeeding period reduces the risk of HIV after a 14 week course of prophylaxis for the infant is stopped – but only in mothers with a CD4 count below 250 cells/mm3. Is infant prophylaxis the better tool for preventing transmission during breastfeeding? Some experts at CROI said yes, but others would prefer to give ART to mothers.

All the summaries link to news reports published at aidsmap.com. You can view all symposia and oral research presentations from the conference online at the conference website http://www.retroconference.org/2009 (although we have not tested the feasibility of doing this over a dial-up internet connection and would note that even over a high-speed broadband connection it can take several minutes for presentations to load). You can also browse the conference programme online and view pdf versions of the vast majority of posters presented.

HATIP #131, 19th February 2009

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.